G6PC1 and Other metabolic disease: The observed decrease in gluconeogenic enzyme mRNA, like G6Pase and PEPCK (Figure 4D), showcases RG saponin’s ability to influence insulin pathways and manage metabolic disorders by fine-tuning critical metabolic processes.